Related references
Note: Only part of the references are listed.Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors
Edward Sausville et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53
Francois H. T. Duong et al.
CARCINOGENESIS (2014)
Increased DNA Damage in Hepatitis C Virus-Related Hepatocellular Carcinoma
Shereen M. Shawki et al.
DNA AND CELL BIOLOGY (2014)
'Liver let die': oxidative DNA damage and hepatotropic viruses
Martin R. Higgs et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
Zhengyan Kan et al.
GENOME RESEARCH (2013)
Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma
Shingo Tanaka et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Genome-Wide Transcriptional Reorganization Associated with Senescence-to-Immortality Switch during Human Hepatocellular Carcinogenesis
Gokhan Yildiz et al.
PLOS ONE (2013)
Hepatitis C Virus NS2 Protein Inhibits DNA Damage Pathway by Sequestering p53 to the Cytoplasm
Cintia Bittar et al.
PLOS ONE (2013)
Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway
Shu-Chen Wei et al.
JOURNAL OF BIOMEDICAL SCIENCE (2013)
CGK733 enhances multinucleated cell formation and cytotoxicity induced by taxol in Chk1-deficient HBV-positive hepatocellular carcinoma cells
Huan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma
Jian Hong et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The Checkpoint Kinase Inhibitor AZD7762 Potentiates Chemotherapy-Induced Apoptosis of p53-Mutated Multiple Myeloma Cells
Heather J. Landau et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells
Meng-Tzu Weng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sensitization of Pancreatic Cancer Stem Cells to Gemcitabine by Chk1 Inhibition
Venkatasubbaiah A. Venkatesha et al.
NEOPLASIA (2012)
Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma
Siyuan Zheng et al.
BMC MEDICAL GENOMICS (2011)
Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition
Leslie A. Parsels et al.
CLINICAL CANCER RESEARCH (2011)
Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response
Arpit Bhargava et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
High-resolution characterization of a hepatocellular carcinoma genome
Yasushi Totoki et al.
NATURE GENETICS (2011)
Anticancer therapy with checkpoint inhibitors: what, where and when?
Michelle D. Garrett et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
DNA repair and synthetic lethality
Gong-she Guo et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2011)
A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
Stephanie Roessler et al.
CANCER RESEARCH (2010)
Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase
Samuel McNeely et al.
CELL CYCLE (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
Abhik Bandyopadhyay et al.
PLOS ONE (2010)
Occult hepatitis B virus infection with low viremia induces DNA damage, apoptosis and oxidative stress in peripheral blood lymphocytes
Arpit Bhargava et al.
VIRUS RESEARCH (2010)
Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C
N. Fujita et al.
JOURNAL OF VIRAL HEPATITIS (2008)
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
Sonya D. Zabludoff et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Noninvasive prediction of prostatic DNA damage by oxidative stress challenge of peripheral blood lymphocytes
David J. Waters et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo
Archie N. Tse et al.
CLINICAL CANCER RESEARCH (2007)
Rad17 phosphorylation is required for claspin recruitment and Chk1 activation in response to replication stress
Xin Wang et al.
MOLECULAR CELL (2006)
The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpoint
CC Ho et al.
EXPERIMENTAL CELL RESEARCH (2005)
Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum
A Burroughs et al.
LANCET ONCOLOGY (2004)
Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells
G Mathonnet et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2004)
Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint
I Hassepass et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes
L Zou et al.
SCIENCE (2003)
Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma
KB Schwarz et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems
M Liu et al.
GENES & DEVELOPMENT (2000)
Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts
ZJ Guo et al.
GENES & DEVELOPMENT (2000)
Share Paper
